Cargando…
Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
Sclerostin is a secreted inhibitor of Wnt/β-catenin signaling that is mainly produced by osteocytes and is an important regulator of bone remodeling. Some studies have evaluated serum sclerostin levels in metabolic bone diseases, but the results have been contradictory. The profile of serum sclerost...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482545/ https://www.ncbi.nlm.nih.gov/pubmed/36124027 http://dx.doi.org/10.1155/2022/7902046 |